GlassScriptPhysician profile
Jose Campos
NPI 1801057997
$1,052.19
in general payments reported to CMS, 2019-2025
7 companies · $92.85 in 2025
The $92.85 reported for 2025 was less than what a typical Sports Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $119).
See the full distribution for Sports Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.04 · 2021: $45.94 · 2022: $15.62 · 2023: $838 · 2024: $31.69 · 2025: $92.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $671 · Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $670.57 |
| Food and Beverage | $292.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $838.05 | 2023 | Iovera, Zilretta |
| Novo Nordisk INC | $81.68 | 2019-2025 | Wegovy |
| Abbvie INC. | $70.90 | 2024-2025 | |
| Medtronic, INC. | $16.92 | 2021 | |
| Boston Scientific Corporation | $16.78 | 2021 | |
| Lilly USA, LLC | $15.62 | 2022 | |
| Sanofi-Aventis U.S. LLC | $12.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Campos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.